San Diego, California–(Newsfile Corp. – July 28, 2021) – Robbins Geller Rudman & Dowd LLP announces the filing of the Athira Pharma course action lawsuit,
Tag: ATHIRA
Buyers With Substantial Losses Have Opportunity to Guide the Athira Pharma, Inc. Class Action Lawsuit
SAN DIEGO, July 20, 2021–(Organization WIRE)–Robbins Geller Rudman & Dowd LLP announces that purchasers of Athira Pharma, Inc. (NASDAQ: ATHA) securities involving September 18, 2020
Robbins Geller Rudman & Dowd LLP Announces Chance for Traders with Significant Losses to Lead the Athira Pharma, Inc. Course Action Lawsuit
SAN DIEGO, July 16, 2021 (Globe NEWSWIRE) — The Athira Pharma class motion lawsuit fees Athira Pharma, Inc. (NASDAQ: ATHA) and its CEO with violations
Shareholders With Considerable Losses Have Prospect to Lead the Athira Pharma, Inc. Class Action Lawsuit
San Diego, California–(Newsfile Corp. – July 15, 2021) – The Athira Pharma course action lawsuit rates Athira Pharma, Inc. (NASDAQ: ATHA) and its CEO with
Buyers With Considerable Losses Have Option to Guide the Athira Pharma, Inc. Class Action Lawsuit
SAN DIEGO, July 14, 2021–(Business enterprise WIRE)–Robbins Geller Rudman & Dowd LLP announces that purchasers of Athira Pharma, Inc. (NASDAQ: ATHA) securities amongst September 18,
ATHIRA PHARMA Trader Recognize: Buyers With Substantial Losses Have Possibility to Lead the Athira Pharma, Inc. Class Motion Lawsuit
SAN DIEGO, July 13, 2021 /PRNewswire/ — The Athira Pharma, Inc. course action lawsuit fees Athira Pharma and its CEO with violations of the Securities